LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.88 | 84.90 | 1686 | 7291 | 0.2312 | 0.5923 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 60.59 | 84.90 | 1880 | 7641 | 0.2460 | 0.6115 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 60.59 | 84.90 | 1934 | 7641 | 0.2531 | 0.6185 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 60.59 | 84.90 | 205 | 7641 | 0.0268 | 0.1454 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 60.59 | 84.90 | 1815 | 7641 | 0.2375 | 0.6027 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 62.29 | 84.90 | 2039 | 7934 | 0.2570 | 0.6251 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 62.29 | 84.90 | 2087 | 7934 | 0.2630 | 0.6309 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 62.29 | 84.90 | 167 | 7934 | 0.0210 | 0.1089 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 62.29 | 84.90 | 1739 | 7934 | 0.2192 | 0.5861 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.99 | 84.90 | 2054 | 8212 | 0.2501 | 0.6210 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.99 | 84.90 | 2096 | 8212 | 0.2552 | 0.6260 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.99 | 84.90 | 177 | 8212 | 0.0216 | 0.1178 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.99 | 84.90 | 1736 | 8212 | 0.2114 | 0.5802 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.70 | 84.90 | 2116 | 8484 | 0.2494 | 0.6227 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.70 | 84.90 | 2145 | 8484 | 0.2528 | 0.6260 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.70 | 84.90 | 204 | 8484 | 0.0240 | 0.1411 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.70 | 84.90 | 1853 | 8484 | 0.2184 | 0.5906 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.41 | 84.90 | 2173 | 8766 | 0.2479 | 0.6236 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.41 | 84.90 | 2208 | 8766 | 0.2519 | 0.6275 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.41 | 84.90 | 196 | 8766 | 0.0224 | 0.1332 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.41 | 84.90 | 1817 | 8766 | 0.2073 | 0.5808 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.11 | 84.90 | 2191 | 8988 | 0.2438 | 0.6214 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.11 | 84.90 | 2223 | 8988 | 0.2473 | 0.6249 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.11 | 84.90 | 210 | 8988 | 0.0234 | 0.1441 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.11 | 84.90 | 1859 | 8988 | 0.2068 | 0.5823 | MN20160318_Q02 | N22 |